-
Loading metrics
Open Access
Peer-reviewed
Research Article
DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma
-
Anthony B. Eason,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliations Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Sang-Hoon Sin,
Roles Conceptualization, Data curation, Methodology, Project administration, Validation, Writing – review & editing
Affiliations Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Mohsin Shah,
Roles Investigation, Methodology, Validation
Affiliations Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Hong Yuan,
Roles Conceptualization, Resources, Writing – review & editing
Affiliation Biomedical Research Imaging Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America
⨯ -
Douglas J. Phillips,
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Resources, Validation, Writing – review & editing
Affiliation Cell Medica, Zurich, Switzerland
⨯ -
Miriam Droste,
Roles Formal analysis, Investigation, Validation, Writing – review & editing
Affiliation Cell Medica, Zurich, Switzerland
⨯ -
Abdijapar Shamshiev,
Roles Formal analysis, Investigation, Validation, Writing – review & editing
Affiliation Cell Medica, Zurich, Switzerland
⨯ -
Dirk P. Dittmer
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Resources, Supervision, Writing – review & editing
* E-mail: ddittmer@med.unc.edu
Affiliations Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States of America
⨯
DLX1008 (brolucizumab), a single-chain anti-VEGF-A antibody fragment with low picomolar affinity, leads to tumor involution in an in vivo model of Kaposi Sarcoma
- Anthony B. Eason,
- Sang-Hoon Sin,
- Mohsin Shah,
- Hong Yuan,
- Douglas J. Phillips,
- Miriam Droste,
- Abdijapar Shamshiev,
- Dirk P. Dittmer
- Published: May 14, 2020
- https://doi.org/10.1371/journal.pone.0233116